Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM CL A NEW
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
213,944
-
Shares change
-
+94,525
-
Total reported value, excl. options
-
$142,250
-
Value change
-
+$64,210
-
Number of buys
-
9
-
Number of sells
-
-2
-
Price
-
$0.6701
Significant Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) as of Q4 2024
20 filings reported holding HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW as of Q4 2024.
HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 213,944 shares
.
Largest 10 shareholders include Virtu Financial LLC (46,510 shares), Grant Private Wealth Management Inc (37,193 shares), UBS Group AG (29,537 shares), TWO SIGMA SECURITIES, LLC (26,235 shares), HRT FINANCIAL LP (23,803 shares), GEODE CAPITAL MANAGEMENT, LLC (21,481 shares), VANGUARD GROUP INC (12,598 shares), Tower Research Capital LLC (TRC) (5,568 shares), IFP Advisors, Inc (5,000 shares), and CITIGROUP INC (4,163 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.